Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

An Arkansas mom of three is sharing her story of overcoming breast cancer, and how an unexpected genetic twist led to some big decisions.

A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.

Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...

The ability to predict spirometry-defined COPD was significantly better when a modified lung function questionnaire score was ...

Kayla Funderburg is a 25-year-old hairstylist who is taking control of her breast cancer risk. After a genetic test, she scheduled a double mastectomy.

Conservative supporters of government deregulation want to do away with state-imposed licensing requirements, a move genetic counselors say will harm patients.

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Integration streamlines the implementation process and enhances the clarity and accessibility of results within the EHR, UNC ...

KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...